GROUP ONE TRADING, L.P. - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 32 filers reported holding TRINITY BIOTECH PLC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$12,154
-24.6%
16,6910.0%0.00%
Q2 2023$16,110
+2.7%
16,6910.0%0.00%
Q1 2023$15,690
-5.0%
16,691
+0.1%
0.00%
Q4 2022$16,509
+1550.9%
16,676
+6030.9%
0.00%
Q1 2021$1,000
-94.4%
272
-94.3%
0.00%
Q4 2020$18,000
+100.0%
4,772
+11.7%
0.00%
Q3 2020$9,000
+800.0%
4,272
+4172.0%
0.00%
Q1 2017$1,0000.0%1000.0%0.00%
Q4 2016$1,0000.0%1000.0%0.00%
Q3 2016$1,0000.0%1000.0%0.00%
Q2 2016$1,0000.0%1000.0%0.00%
Q1 2016$1,000
-97.6%
100
-95.6%
0.00%
-100.0%
Q2 2015$41,000
-71.7%
2,265
-71.5%
0.00%
-50.0%
Q3 2014$145,000
+5.1%
7,950
+32.4%
0.00%0.0%
Q2 2014$138,000
-88.0%
6,005
-86.9%
0.00%
-88.2%
Q4 2013$1,154,000
+75.4%
45,890
+51.7%
0.02%
+30.8%
Q3 2013$658,000
+121.5%
30,243
+71.3%
0.01%
+85.7%
Q2 2013$297,00017,6510.01%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Prospect Capital Advisors, LLC 336,550$3,924,0004.65%
ACK Asset Management 979,600$11,422,0004.49%
Balter Liquid Alternatives, LLC 161,284$1,881,0004.33%
GOLDMAN CAPITAL MANAGEMENT INC 396,690$4,625,0003.50%
Paradice Investment Management LLC 1,435,724$16,741,0002.23%
Adirondack Research & Management Inc. 415,353$4,843,0001.76%
Lapides Asset Management, LLC 705,100$8,221,0001.47%
Park West Asset Management LLC 900,000$10,494,0000.99%
Benchmark Capital Advisors 83,541$974,0000.86%
HEARTLAND ADVISORS INC 1,290,010$15,042,0000.79%
View complete list of TRINITY BIOTECH PLC shareholders